Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) board of directors audit committee
2021 annual performance report
In accordance with the company law, the standards for the governance of listed companies issued by the China Securities Regulatory Commission, the Listing Rules of Shanghai Stock Exchange, the self regulatory guidelines for listed companies of Shanghai Stock Exchange No. 1 – standardized operation, the articles of association, the rules of procedure of the audit committee of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) board of directors and other relevant provisions, The Audit Committee (hereinafter referred to as the “Audit Committee”) of the board of directors of Zhejiang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Pharmaceutical Co., Ltd. (hereinafter referred to as the “company”) is responsible to the company and all shareholders, diligent and responsible, practically and effectively supervises the external audit of listed companies, guides the internal audit of the company, promotes the company to establish effective internal control and provides true, accurate and complete financial reports, and provides scientific, accurate and complete services for the board of directors Efficient decision-making provides professional support. The work report of the Committee in 2021 is as follows:
1、 Basic information of the audit committee
The company held the first meeting of the third board of directors on April 19, 2019, deliberated and passed the proposal on electing members of the special committee of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) the third board of directors, and elected Mr. Han Haimin, Ms. Zhang Yinan and Ms. Zheng Huaxian as members of the committee, of which Mr. Han Haimin served as the chairman.
2、 Meetings of the audit committee
During the reporting period, the audit committee of the company held four meetings. All members earnestly fulfilled their obligations of loyalty and diligence, gave full play to and made use of their professional advantages, and provided important opinions and suggestions for the scientific and efficient decision-making of the board of directors. The details are as follows:
Meeting time and matters to be considered at the session
1. 2020 performance report of Audit Committee of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) board of directors
2. Calculation report of the third board of directors for Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) 2020 financial decision
On April 14, 2021, the first 3 meetings of the Committee in 2021 and Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) 2020 annual report (full text and summary)
4. Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) 2021 annual plan for daily connected transactions
5. Proposal on reappointment of the company’s audit institution in 2021
Audit report of the third board of directors for the first quarter of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) 2021 April 16, 2021 second quarter of 2021
Report of the meeting
Audit of the third board of directors 1. The Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) 2020 semi annual report August 23, 2021 and the third report of the Committee in 2021 (full text and abstract)
Meeting 2. Special report on the deposit and actual use of raised funds in the half year of 2021
Audit report of the third quarter of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) 2021 of the third board of directors on October 26, 2021
Report of the meeting
3、 Performance of the audit committee in 2021
1. Supervise and evaluate the work of external audit institutions
On the basis of investigation and evaluation, members made a fair and objective evaluation and summary of the audit work of Lixin Certified Public Accountants (special general partnership) in 2021, and believed that Lixin Certified Public Accountants (special general partnership) has the qualification of securities industry, has rich experience in the audit of listed companies, and adheres to the principles of independent, objective and fair audit in the process of practice, Be able to complete the work entrusted by the company within the agreed time limit. The audit committee proposed to the board of directors to renew the appointment of Lixin Certified Public Accountants (special general partnership) as the audit institution of the company in 2022.
2. Guide internal audit
During the reporting period, the company focused on the standardization and effectiveness of internal audit work. Members carefully reviewed the company’s internal audit work plan and summary, urged the company’s internal audit department to strictly implement the audit plan, and put forward guiding opinions on the internal audit work, which promoted the effective operation of the internal audit department. After reviewing the internal audit work report, no major problems were found in the internal audit work.
3. Review and comment on the company’s financial report
During the reporting period, the audit committee carefully reviewed the audited 2021 financial and accounting report prepared by the company. The Committee believes that the company’s financial report is true, accurate and complete, prepared in accordance with the accounting standards for business enterprises and the company’s financial system, and fairly reflects the company’s financial position, operating results and cash flow in 2021, There is no fraud or fraud or other major errors, and there is no adjustment of major accounting errors, major changes in accounting policies and estimates.
4. Evaluate the effectiveness of internal control
During the reporting period, the audit committee guided the internal control department of the company to seriously carry out internal control work, establish and improve the internal control system, implement the requirements of relevant system norms, strengthen the supervision and inspection of the implementation of the internal control system, and completed the self-evaluation of the company’s internal control in 2021. All members gave full play to their professional advantages and actively promoted the construction of the company’s governance structure and internal control system. The Committee believes that the company has established a relatively sound and perfect internal control management system. The company has maintained effective internal control in all major aspects in accordance with the basic norms of enterprise internal control and other relevant provisions this year, effectively protecting the overall interests of the company and the legitimate rights and interests of shareholders.
5. Coordinate the communication between management, internal audit department and external audit institutions
During the reporting period, the audit committee maintained timely and effective information communication with the company’s management, internal audit department, Lixin certified public accountants and other relevant parties, actively coordinated the work of all parties, improved the efficiency of audit work, and effectively ensured that all audit work of the company was completed in time according to the established time and plan.
4、 Overall evaluation
During the reporting period, the audit committee earnestly fulfilled the obligations of loyalty and diligence in accordance with the relevant provisions of the Shanghai Stock Exchange self regulatory guidelines for listed companies of Shanghai Stock Exchange No. 1 – standardized operation and the rules of procedure of the audit committee of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) board of directors, so as to promote the improvement of the company’s internal control management level and prevent business risks, It has played an active and effective role in improving financial management and legal compliance, and better fulfilled the responsibilities of the audit committee.
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) board of directors audit committee March 31, 2022
